Lung cancer is still the top cancer killer, but new developments are shifting what the future might hold for patients.

Daraxonrasib (Rasonque), recently approved for the treatment of metastatic pancreatic cancer, is also showing promise in the treatment of lung cancer in early trials.

Researchers at The University of Texas MD Anderson Cancer Center have developed an artificial intelligence (AI) model that ...

Dr. Jia Luo explains how chemotherapy, targeted therapy and immunotherapy work for lung cancer, plus tips for managing treatment side effects. Understanding lung cancer treatment can feel overwhelming ...

Lung cancer incidence decreased 3.5%/year in males and 1.9%/year in females during 2018–2022, alongside a two-thirds increase ...

Stage 4 lung cancer is often viewed as a final and untreatable diagnosis. However, thanks to medical progress and new technologies, patients today have far more treatment options than they did even a ...

Most lung cancers aren’t diagnosed until you’re older. In fact, on average, lung cancer shows up around the age of 70. The most common type is non-small-cell lung cancer (NSCLC), which grows from the ...

he Ohio State University Comprehensive Cancer Center is starting a first-of-its-kind clinical trial to see whether psilocybin ...

If you’re 65 or older and newly diagnosed with non-small-cell lung cancer (NSCLC), you may wonder if your age will direct or potentially limit your treatment options and approach. Although age is a ...

Non-dilutive federal funding will support preclinical and clinical work validating red blood cell-bound tumor DNA as an early ...